B cells versus T cells as primary barrier to hematopoietic engraftment in allosensitized recipients

Blood

Volumn 113, Issue 5, 2009, Pages 1205-

  Storb, Rainer ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROCARBAZINE; THYMOCYTE ANTIBODY; ALLOANTIBODY;

B LYMPHOCYTE; CELL TRANSPLANTATION; CELLULAR IMMUNITY; ENGRAFTMENT; GRAFT REJECTION; HEMATOPOIETIC CELL; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; LETTER; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; ANIMAL; ANTIBODY PRODUCTION; BIOSYNTHESIS; BONE MARROW TRANSPLANTATION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE DEPLETION; MALE; MOUSE; MOUSE STRAIN; NOTE; SKIN TRANSPLANTATION;

ANIMALS; ANTIBODY FORMATION; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE TOLERANCE; ISOANTIBODIES; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED STRAINS; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 60849107286     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-09-177436     Document Type: Letter

References (11)

1. Xu H, Chilton PM, Tanner MK, et al. Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. Blood. 2006; 108:3611-3619.
2. Taylor PA, Ehrhardt MJ, Roforth MM, et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood. 2007;109:1307-1315.
3. Garver RM, Cole LJ. Passive transfer of bone marrow homotransplantation immunity with specific antisera. J Immunol. 1961;86:307-311.
4. Loutit JF, Micklem HS. Active and passive immunity to transplantation of foreign bone marrow in lethally irradiated mice. Br J Exp Pathol. 1961;42: 577-586.
5. Storb R, Prentice RL, Thomas ED. Marrow transplantation for treatment of aplastic anemia: an analysis of factors associated with graft rejection. N Engl J Med. 1977;296:61-66.
6. Storb R, Epstein RB, Rudolph RH, Thomas ED. The effect of prior transfusion on marrow grafts between histocompatible canine siblings. J Immunol. 1970; 105:627-633.
7. Storb R, Rudolph RH, Graham TC, Thomas ED. The influence of transfusions from unrelated donors upon marrow grafts between histocompatible canine siblings. J Immunol. 1971;107:409-413.
8. Warren RP, Storb R, Weiden PL, Mickelson EM, Thomas ED. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes: correlation with marrow graft rejection. Transplantation. 1976;22: 631-635.
9. Storb R, Hansen JA, Weiden PL, Clift RA, Thomas ED. Pretransplant lymphocytotoxins do not predict bone marrow graft rejection. Transplantation. 1978; 26:423-425.
10. Storb R, Floersheim GL, Weiden PL, et al. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. J Immunol. 1974;112:1508-1516.
11. Weiden PL, Storb R, Slichter S,Warren RP, Sale GE. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum. J Immunol. 1976;117:143-150.